$291 Million is the total value of Eagle Health Investments LP's 29 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 48.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $23,947,000 | +35.0% | 399,789 | +12.1% | 8.22% | +18.0% |
| HUM | Buy | HUMANA INC | $21,127,000 | +12.2% | 47,721 | +6.2% | 7.25% | -1.9% |
| IQV | Sell | IQVIA HLDGS INC | $20,664,000 | +6.8% | 85,277 | -14.9% | 7.09% | -6.6% |
| NTRA | Sell | NATERA INC | $18,527,000 | +8.4% | 163,194 | -3.1% | 6.36% | -5.3% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $18,339,000 | +20.1% | 108,179 | 0.0% | 6.29% | +4.9% | |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $17,589,000 | +12.9% | 98,038 | +5.3% | 6.03% | -1.3% |
| ARGX | Buy | ARGENX SEsponsored adr | $16,027,000 | +36.5% | 53,232 | +24.9% | 5.50% | +19.3% |
| AXNX | Buy | AXONICS INC | $14,874,000 | +27.4% | 234,565 | +20.3% | 5.10% | +11.3% |
| DXCM | Buy | DEXCOM INC | $14,603,000 | +194.4% | 34,200 | +147.8% | 5.01% | +157.3% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $14,143,000 | -25.6% | 70,144 | -20.7% | 4.85% | -35.0% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $12,979,000 | -29.1% | 235,513 | -33.6% | 4.45% | -38.0% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $12,382,000 | -4.4% | 140,763 | +5.7% | 4.25% | -16.4% |
| INSP | Buy | INSPIRE MED SYS INC | $10,833,000 | +39.7% | 56,053 | +49.7% | 3.72% | +22.1% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $10,535,000 | +29.4% | 257,827 | +27.5% | 3.61% | +13.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $9,353,000 | +50.0% | 57,900 | +59.1% | 3.21% | +31.1% |
| OM | Buy | OUTSET MED INC | $9,296,000 | +75.7% | 186,000 | +91.2% | 3.19% | +53.5% |
| AMWL | New | AMERICAN WELL CORPcl a | $9,153,000 | – | 727,600 | +100.0% | 3.14% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $6,013,000 | +45.9% | 161,125 | 0.0% | 2.06% | +27.6% | |
| CANO | New | CANO HEALTH INC | $6,003,000 | – | 496,100 | +100.0% | 2.06% | – |
| CMAX | New | CAREMAX INC | $4,873,000 | – | 377,775 | +100.0% | 1.67% | – |
| PRVA | New | PRIVIA HEALTH GROUP INC | $4,260,000 | – | 96,000 | +100.0% | 1.46% | – |
| GH | GUARDANT HEALTH INC | $3,510,000 | -18.6% | 28,260 | 0.0% | 1.20% | -28.9% | |
| SEER | SEER INC | $2,737,000 | -34.5% | 83,500 | 0.0% | 0.94% | -42.7% | |
| KYMR | New | KYMERA THERAPEUTICS INC | $1,795,000 | – | 37,000 | +100.0% | 0.62% | – |
| CCCC | New | C4 THERAPEUTICS INC | $1,786,000 | – | 47,200 | +100.0% | 0.61% | – |
| ARVN | New | ARVINAS INC | $1,771,000 | – | 23,000 | +100.0% | 0.61% | – |
| LYEL | New | LYELL IMMUNOPHARMA INC | $1,624,000 | – | 100,000 | +100.0% | 0.56% | – |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $1,375,000 | -36.6% | 57,090 | +14.2% | 0.47% | -44.5% |
| OLK | OLINK HLDG ABsponsored ads | $1,377,000 | -4.4% | 40,000 | 0.0% | 0.47% | -16.5% | |
| DFHT | Exit | DEERFIELD HEALTHCARE TECH AC | $0 | – | -340,075 | -100.0% | -1.62% | – |
| JWS | Exit | JAWS ACQUISITION CORP | $0 | – | -496,100 | -100.0% | -2.58% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DELput | $0 | – | -50,000 | -100.0% | -3.28% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -20,951 | -100.0% | -3.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.